secwatch.observer — SEC 8-K summary
======================================

Issuer:     NexImmune, Inc. (—)
CIK:        0001538210
Form:       8-K
Filed at:   2022-10-28T23:59:59+00:00
Accession:  0001193125-22-272490
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NexImmune receives Nasdaq deficiency notice for bid price below $1.00
---------------------------------------------------------------------

- Deficiency letter received Oct 25, 2022; stock closed below $1.00 for 30 consecutive business days.
- Company has 180 days, until April 24, 2023, to regain compliance with Minimum Bid Price Requirement.
- If non-compliant, may transfer listing to Nasdaq Capital Market or face delisting.
- Company may consider options including reverse stock split to cure deficiency.
- No immediate effect on listing; stock continues trading on Nasdaq under symbol NEXI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1538210/000119312522272490/0001193125-22-272490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1538210/000119312522272490/d405955d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-272490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer